Survodutide for Weight Loss in People with Obesity

SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

Recruiting Phase 3 Interventional Study
Obesity
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
350 (estimated)
Sponsor
Boehringer Ingelheim · Industry
Who this trial is looking for

This trial is looking for adults who are overweight or obese and have not been able to lose weight through dieting. Participants will take an injection of a medicine called survodutide once a week for about 14 months while visiting the study site several times and completing questionnaires about their health and weight.

Are You a Good Fit for This Trial?
Rules you out Cushing SyndromeMelanocortin 4 receptor deficiencyLeptin deficiencyPrader Willi Syndrome

You may be able to join if

  • I am at least 18 years old.
  • I have tried to lose weight by dieting at least once without success.
  • I can give permission to join the study on my own.
  • I am willing to use effective birth control if I can become pregnant.

You may not be able to join if

  • I have gained or lost more than 2.5% of my body weight recently.
  • I have obesity caused by other medical conditions.
  • My blood test shows a hemoglobin A1c level of 6.5% or higher.
  • I have a history of Type 1 or Type 2 diabetes.
  • I have taken diabetes medications in the past 3 months.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study is open to adults with overweight or obesity. People can join the study if they have a body mass index (BMI) of 30 kg/m² or more, or a BMI of 27 kg/m² or more with at least one weight- related health problem. Participants must not have diabetes, and they must have tried to lose weight by dieting at least once in the past without success. The purpose of this study is to find out whether …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: 1. Male or female, age ≥18 years at the time of signing informed consent, and at least the legal age of consent in countries where it is \>18 years 2. History of at least one self-reported unsuccessful dietary effort to lose body weight 3. Signed and dated written informed conse…
Contacts

Boehringer Ingelheim

1-800-243-0127

clintriage.rdg@boehringer-ingelheim.com

CONTACT